Evidence map›Paper›PMID 19786798›Full record

ReviewInternational archives of allergy and immunology2010

The role of costimulatory molecules in allergic disease and asthma.

Vincent Lombardi, Abinav K Singh, Omid Akbari

Abstract readReview
In one paragraph

Review in International archives of allergy and immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Involvement of the PD-1 pathway in the modulation of immune responses during allergic diseases.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Regulatory T Cells in Allergy and Asthma.Frontiers in pediatrics · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Vincent LombardiDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033-9605, USA.
Abinav K Singh
Omid Akbari

Funding

Role of NKT cells in airway hyperreactivity & toleranceR01AI066020 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI AKBARI, OMID · 2007 to 2011
$1.6M
NIAID NIH HHS NIH R01 AI066020NIAID NIH HHS R01 AI066020
6 · The paper itself

Abstract

The prevalence of allergic diseases has increased rapidly in recent years. It is well established that the deleterious allergic response is initiated by T-cell recognition of major histocompatibility class II-peptide complexes at the surface of antigen-presenting cells. While this first signal gives antigen specificity to the adaptive immune response, a second nonspecific costimulatory signal is required by T cells to become fully activated. This signal is provided by interactions between antigen-presenting cells and T cells through molecules borne at the surfaces of the two cell types. Depending on the type of molecules involved, this secondary signal can promote the development of an inflammatory allergic reaction or may favor immune regulation. Several molecules of the B7 family (CD80, CD86, PD-1, ICOS, CTLA-4) and tumor necrosis factor receptor family (OX40, CD30, 4-1BB, Fas, CD27, CD40) play an important role in delivering costimulatory signals in early and late phases of allergic response. Therefore, costimulatory molecules involved in promotion or prevention of allergic immune responses are potential targets for the development of novel therapeutic approaches. This review aims to recapitulate our current understanding of the relationship between allergic diseases and costimulatory molecules.

Indexed as

AnimalsAntigens, CDAntigens, Differentiation, T-LymphocyteAsthmaB7-1 AntigenB7-2 AntigenB7 AntigensB7-H1 AntigenHumansHypersensitivityInducible T-Cell Co-Stimulator ProteinIntercellular Signaling Peptides and ProteinsProgrammed Cell Death 1 Ligand 2 ProteinReceptors, ImmunologicReceptors, Tumor Necrosis FactorAntigens, CDAntigens, Differentiation, T-LymphocyteB7-1 AntigenB7-2 AntigenB7 AntigensB7-H1 AntigenCD274 protein, humanCD276 protein, humanICOS protein, humanInducible T-Cell Co-Stimulator ProteinIntercellular Signaling Peptides and ProteinsPDCD1LG2 protein, humanProgrammed Cell Death 1 Ligand 2 ProteinReceptors, ImmunologicReceptors, Tumor Necrosis Factor

Identifiers

PMID19786798
PMCPMC2837887

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.